140 related articles for article (PubMed ID: 37629505)
21. Editorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2.
Parums DV
Med Sci Monit; 2023 Sep; 29():e942244. PubMed ID: 37654205
[TBL] [Abstract][Full Text] [Related]
22. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
[TBL] [Abstract][Full Text] [Related]
23. Changing predominant SARS-CoV-2 lineages drives successive COVID-19 waves in Malaysia, February 2020 to March 2021.
Sam IC; Chong YM; Abdullah A; Fu JYL; Hasan MS; Jamaluddin FH; Kamarulzaman A; Lim KK; Mohd Nor MA; Pang YK; Ponnampalavanar S; Shahib MF; Syed Omar SF; Chan JCJ; Perera D; Chan YF
J Med Virol; 2022 Mar; 94(3):1146-1153. PubMed ID: 34757638
[TBL] [Abstract][Full Text] [Related]
24. Genomic Surveillance of SARS-CoV-2 Variants That Emerged in South and Southeast Asia during Early 2022.
Yu Q; Tong X; Zuo L; Tao X; Xu Z; Li X; Liu H; Guan W; Liu D; Liu H; Huang F; Jia L
Viruses; 2023 Jun; 15(6):. PubMed ID: 37376654
[TBL] [Abstract][Full Text] [Related]
25. Wastewater surveillance of SARS-CoV-2 variants in October-November 2022 in Italy: detection of XBB.1, BA.2.75 and rapid spread of the BQ.1 lineage.
La Rosa G; Brandtner D; Bonanno Ferraro G; Veneri C; Mancini P; Iaconelli M; Lucentini L; Del Giudice C; Orlandi L; ; Suffredini E
Sci Total Environ; 2023 May; 873():162339. PubMed ID: 36813191
[TBL] [Abstract][Full Text] [Related]
26. Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5.
Torres C; Nabaes Jodar M; Acuña D; Montaño RMZ; Culasso ACA; Amadio AF; Aulicino P; Ceballos S; Cacciabue M; Debat H; Dus Santos MJ; Eberhardt MF; Espul C; Fay F; Fernández MA; Fernández F; Muñoz JMF; Ferrini F; Gallego F; Giri AA; Cerri A; Bolatti E; Gismondi MI; Goya S; Gramundi I; Irazoqui JM; König GA; Leiva V; Lucero H; Marquez N; Nardi C; Ortiz B; Pianciola L; Pintos CB; Puebla AF; Rastellini CV; Rojas AE; Sfalcin J; Suárez A; Tittarelli E; Toro R; Villanova GV; Ziehm MC; Zimmermann MC; Zunino S; Proyecto Pais Working Group ; Valinotto L; Viegas M
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851525
[TBL] [Abstract][Full Text] [Related]
27. Emerging SARS-CoV-2 Variants and Subvariants: Challenges and Opportunities in the Context of COVID-19 Pandemic.
Rahman S; Hossain MJ; Nahar Z; Shahriar M; Bhuiyan MA; Islam MR
Environ Health Insights; 2022; 16():11786302221129396. PubMed ID: 36299441
[TBL] [Abstract][Full Text] [Related]
28. Serum neutralization of SARS-CoV-2 Omicron BA.2, BA.2.75, BA.2.76, BA.5, BF.7, BQ.1.1 and XBB.1.5 in individuals receiving Evusheld.
Zhao Q; Wang X; Zhang Z; Liu X; Wang P; Cao J; Liang Q; Qu J; Zhou M
J Med Virol; 2023 Jul; 95(7):e28932. PubMed ID: 37403923
[TBL] [Abstract][Full Text] [Related]
29. Monitoring of SARS-CoV-2 concentration and circulation of variants of concern in wastewater of Leuven, Belgium.
Rector A; Bloemen M; Thijssen M; Delang L; Raymenants J; Thibaut J; Pussig B; Fondu L; Aertgeerts B; Van Ranst M; Van Geet C; Arnout J; Wollants E
J Med Virol; 2023 Feb; 95(2):e28587. PubMed ID: 36799251
[TBL] [Abstract][Full Text] [Related]
30. Omicron variant evolution on vaccines and monoclonal antibodies.
Sabbatucci M; Vitiello A; Clemente S; Zovi A; Boccellino M; Ferrara F; Cimmino C; Langella R; Ponzo A; Stefanelli P; Rezza G
Inflammopharmacology; 2023 Aug; 31(4):1779-1788. PubMed ID: 37204696
[TBL] [Abstract][Full Text] [Related]
31. Temporal lineage replacements and dominance of imported variants of concern during the COVID-19 pandemic in Kenya.
Kimita G; Nyataya J; Omuseni E; Sigei F; Lemtudo A; Muthanje E; Andika B; Liyai R; Githii R; Masakwe C; Ochola S; Awinda G; Kifude C; Mutai B; Gatata RM; Waitumbi J
Commun Med (Lond); 2022; 2():103. PubMed ID: 35982756
[TBL] [Abstract][Full Text] [Related]
32. In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.
Sharma D; Notarte KI; Fernandez RA; Lippi G; Gromiha MM; Henry BM
J Med Virol; 2023 Jan; 95(1):e28241. PubMed ID: 36263448
[TBL] [Abstract][Full Text] [Related]
33. Analysis of SARS-CoV-2 genomic surveillance data during the Delta and Omicron waves at a Saudi tertiary referral hospital.
Obeid D; Al-Qahtani A; Almaghrabi R; Alghamdi S; Alsanea M; Alahideb B; Almutairi S; Alsuwairi F; Al-Abdulkareem M; Asiri M; Alshukairi A; Alkahtany J; Altamimi S; Mutabagani M; Althawadi S; Alanzi F; Alhamlan F
J Infect Public Health; 2023 Feb; 16(2):171-181. PubMed ID: 36543031
[TBL] [Abstract][Full Text] [Related]
34. A recombinant spike-XBB.1.5 protein vaccine induces broad-spectrum immune responses against XBB.1.5-included Omicron variants of SARS-CoV-2.
He C; Alu A; Lei H; Yang J; Hong W; Song X; Li J; Yang L; Wang W; Shen G; Lu G; Wei X
MedComm (2020); 2023 Jun; 4(3):e263. PubMed ID: 37125241
[TBL] [Abstract][Full Text] [Related]
35. Genomic Surveillance for SARS-CoV-2 Variants of Concern from Imported COVID-19 Cases - the Mainland of China, 2021.
Feng Y; Zhao X; Chen Z; Nie K; Yin Z; Xia Y; Wang J; Niu P; A R; Li L; Wang D; Tan W; Ma X; Wang S; Wang H; Gao GF; Chen C; Xu W
China CDC Wkly; 2022 Aug; 4(31):680-684. PubMed ID: 36059791
[TBL] [Abstract][Full Text] [Related]
36. XBB.1, BQ1.1 and atypical BA.4.6/XBB.1 recombinants predominate current SARS-CoV-2 Wavelets with flu-like symptoms in Cameroon: A snapshot from genomic surveillance.
Fokam J; Ngoufack Jagni Semengue E; Gouissi Anguechia DH; Etame NK; Takou D; Mandeng N; Kengni Ngueko MA; Beloumou Angong G; Djupsa Ndjeyep S; Chenwi Ambe C; Nka AD; Molimbou E; Mundo Nayang AR; Moko Fotso LG; Tambe Ayuk Ngwese D; Tueguem PP; Tommo Tchouaket CM; Ka'e AC; Fainguem N; Abega Abega C; Halle-Ekane EG; Esso L; Etoundi Mballa AG; Shang J; Ndongmo CB; Cappelli G; Kifle Tessema S; Z-K Bissek AC; Colizzi V; Ndjolo A; Perno CF; Ndembi N
PLOS Glob Public Health; 2024; 4(5):e0003153. PubMed ID: 38728356
[TBL] [Abstract][Full Text] [Related]
37. Genomic surveillance of SARS-CoV-2 in North Africa: 4 years of GISAID data sharing.
Hamzaoui Z; Ferjani S; Medini I; Charaa L; Landolsi I; Ben Ali R; Khaled W; Chammam S; Abid S; Kanzari L; Ferjani A; Fakhfakh A; Kebaier D; Bouslah Z; Ben Sassi M; Trabelsi S; Boutiba-Ben Boubaker I
IJID Reg; 2024 Jun; 11():100356. PubMed ID: 38655560
[TBL] [Abstract][Full Text] [Related]
38. Temporal dynamics and fatality of SARS-CoV-2 variants in Bangladesh.
Rahman MS; Hoque MN; Chowdhury SR; Siddique MM; Islam OK; Galib SM; Islam MT; Hossain MA
Health Sci Rep; 2023 Apr; 6(4):e1209. PubMed ID: 37077184
[TBL] [Abstract][Full Text] [Related]
39. Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
Link-Gelles R; Ciesla AA; Roper LE; Scobie HM; Ali AR; Miller JD; Wiegand RE; Accorsi EK; Verani JR; Shang N; Derado G; Britton A; Smith ZR; Fleming-Dutra KE
MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(5):119-124. PubMed ID: 36730051
[TBL] [Abstract][Full Text] [Related]
40. Neutralizing Activity against BQ.1.1, BN.1, and XBB.1 in Bivalent COVID-19 Vaccine Recipients: Comparison by the Types of Prior Infection and Vaccine Formulations.
Hyun HJ; Choi MJ; Nham E; Seong H; Yoon JG; Noh JY; Cheong HJ; Kim WJ; Yoon SK; Park SJ; Gwak WS; Lee JW; Kim BG; Song JY
Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
